-
Investors Should Watch: Quicksilver Resources (NYSE:KWK), MGIC Investment (NYSE:MTG), Clifton Bancorp Inc. (NASDAQ:CSBK), Pernix Therapeutics Holdings (NASDAQ:PTX), ArcelorMittal (NYSE:MT)
Quicksilver Resources Inc. (NYSE:KWK) has been one of the several energy sector stalks which have been struck hard by the global oil gut and ensuing drop in oil prices. However, Christmas, it appears to have bought good tiding for the energy sector. Quicksilver Resources Inc. (NYSE:KWK) in last trading activity fell -10.98% to close at…
-
Watch 5 Stocks: The Charles Schwab Corporation (NYSE:SCHW), American Airlines Group Inc. (NASDAQ:AAL), Hemisphere Media (NASDAQ:HMTV), NOW Inc. (NYSE:DNOW), Pernix Therapeutics (NASDAQ:PTX)
The Charles Schwab Corporation (NYSE:SCHW) CEO Walter W. Bettinger sold 759,220 shares of the stock in a transaction dated Friday, December 5th. The shares were sold at an average price of $30.01, for a total transaction of $22,784,192.20. The Charles Schwab Corporation (NYSE:SCHW) in last trading activity advanced 0.03% to close at $30.67. Company weekly…
-
Stocks Swings: Wells Fargo & Company (NYSE:WFC), Encana Corporation (NYSE:ECA), EverBank Financial Corp. (NYSE:EVER), Pernix Therapeutics Holdings (NASDAQ:PTX), Hewlett-Packard Company (NYSE:HPQ)
As one of the nation’s top mortgage lenders, Wells Fargo & Company (NYSE:WFC) employs over 7,000 mortgage consultants and is readily looking for ways it can build its outreach tactics to recruit mortgage lenders. Wells Fargo & Company (NYSE:WFC) in last trading activity decreased -0.95% to close at $53.19. Company weekly performance is -2.88% while…
-
Stock Alert: Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), eBay Inc. (NASDAQ:EBAY), Golub Capital BDC (NASDAQ:GBDC), Rally Software Development Corp. (NYSE:RALY), Pernix Therapeutics (NASDAQ:PTX)
Shares of Navidea Biopharmaceuticals (NYSEMKT:NAVB) saw a significant increase in short interest in the month of November. As of November 28th, there was short interest totalling 29,474,696 shares, an increase of 15.8% from the November 14th total of 25,448,238 shares, Analyst Ratings Network reports. Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB) in last trading activity advanced 0.78% to…
-
Investors Are Eying On: Apache Corp. (NYSE:APA), NorthStar Realty Finance (NYSE:NRF), Pernix Therapeutics (NASDAQ:PTX), Air Products & Chemicals (NYSE:APD), Gladstone Investment (NASDAQ:GAIN)
On 20 November Apache Corp. (NYSE:APA), the producer that embraced a breakup after pressure from Jana Partners LLC, plans to reduce spending in North America by 25 percent next year as falling oil prices make drilling prospects less profitable on the continent. Apache Corp. (NYSE:APA) in last trading activity decreased -2.55% to close at $61.64.…
-
Top Stories: Pernix Therapeutics Holdings (NASDAQ:PTX), Motorola Solutions (NYSE:MSI), Fibrocell Science (NASDAQ:FCSC), Ares Management, L.P. (NYSE:ARES), ServiceSource International (NASDAQ:SREV)
Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)on 17 November announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for TREXIMET (sumatriptan / naproxen sodium) to seek approval for use in adolescent patients, age 12 – 17, for the acute treatment of migraine with or without aura. Pernix Therapeutics…
-
Small Cap Gainers to Watch: Hecla Mining Co. (NYSE:HL), New Gold (NYSEMKT:NGD), Hovnanian Enterprises (NYSE:HOV), Pernix Therapeutics (NASDAQ:PTX), AcelRx Pharmaceuticals (NASDAQ:ACRX)
Silver producer Hecla Mining Co (NYSE:HL) on 5 November reported third-quarter net earnings to stockholders of $3.5 million or $0.01 per share compared with a loss of $8.6 million or $0.03 per share last year. Excluding items, adjusted loss for the quarter was $0.01 per share compared with a loss of $0.02 per share a…
-
Drug most Volatile Stocks: Synergy Pharmaceuticals Inc (NASDAQ:SGYP), Pernix Therapeutics Holdings (NASDAQ:PTX), Depomed Inc (NASDAQ:DEPO), MEI Pharma (NASDAQ:MEIP)
Synergy Pharmaceuticals Inc(NASDAQ:SGYP), a developer of drugs for gastrointestinal disorders, increased the most in a year on investor optimism that its experimental treatment for irritable bowel syndrome may have helped patients in a study. Shares of Synergy Pharmaceuticals Inc(NASDAQ:SGYP)closed at $4.89 in last trading session. Yesterday share price of the company was traded in the…